Atlas Trials

Stable Renal Recipients

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stable Renal Recipients

RecordFirmDate
A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients (NCT01742676)Astellas Pharma Korea, Inc.2011-04-01

Track Stable Renal Recipients automatically

Every clearance here is in the API, with alerts when new ones post.